2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one

C41H49N13O2 — CID 157151581

IUPAC2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one
SMILESCN(c1ccc(-c2ccc(-c3cn[nH]c3)[nH]c2=O)nn1)C1CC(C)(C)NC(C)(C)C1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CC3(CCNC3)C2)nn1
InChIInChI=1S/C22H29N7O.C19H20N6O/c1-21(2)10-15(11-22(3,4)28-21)29(5)19-9-8-18(26-27-19)16-6-7-17(25-20(16)30)14-12-23-24-13-14;26-17-7-13(14-8-21-22-9-14)1-2-15(17)16-3-4-18(24-23-16)25-11-19(12-25)5-6-20-10-19/h6-9,12-13,15,28H,10-11H2,1-5H3,(H,23,24)(H,25,30);1-4,7-9,20,26H,5-6,10-12H2,(H,21,22)
InChIKeyALHWAQGOCSOQSV-UHFFFAOYSA-N
MW755.93 g/mol
LogP5.01
Rot. Bonds7

About 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one

2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one (PubChem CID 157151581) has the molecular formula C41H49N13O2 and a molecular weight of 755.93 g/mol. Its IUPAC name is 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one.

Molecular Properties

Compound Name2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one
PubChem CID157151581
Molecular FormulaC41H49N13O2
Molecular Weight755.93 g/mol
Exact Mass755.41
IUPAC Name2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one
SMILESCN(c1ccc(-c2ccc(-c3cn[nH]c3)[nH]c2=O)nn1)C1CC(C)(C)NC(C)(C)C1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CC3(CCNC3)C2)nn1
InChIInChI=1S/C22H29N7O.C19H20N6O/c1-21(2)10-15(11-22(3,4)28-21)29(5)19-9-8-18(26-27-19)16-6-7-17(25-20(16)30)14-12-23-24-13-14;26-17-7-13(14-8-21-22-9-14)1-2-15(17)16-3-4-18(24-23-16)25-11-19(12-25)5-6-20-10-19/h6-9,12-13,15,28H,10-11H2,1-5H3,(H,23,24)(H,25,30);1-4,7-9,20,26H,5-6,10-12H2,(H,21,22)
InChIKeyALHWAQGOCSOQSV-UHFFFAOYSA-N
XLogP5.01
TPSA192.55 Ų
H-Bond Donors6
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms56
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500755.93
LogP ≤ 55.01
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1012

Analyze 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one?
The IUPAC name of 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one (CID 157151581) is 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one.
What is the SMILES notation for 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one?
The canonical SMILES for 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one is CN(c1ccc(-c2ccc(-c3cn[nH]c3)[nH]c2=O)nn1)C1CC(C)(C)NC(C)(C)C1.Oc1cc(-c2cn[nH]c2)ccc1-c1ccc(N2CC3(CCNC3)C2)nn1.
What is the InChIKey of 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one?
The InChIKey is ALHWAQGOCSOQSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H29N7O.C19H20N6O/c1-21(2)10-15(11-22(3,4)28-21)29(5)19-9-8-18(26-27-19)16-6-7-17(25-20(16)30)14-12-23-24-13-14;26-17-7-13(14-8-21-22-9-14)1-2-15(17)16-3-4-18(24-23-16)25-11-19(12-25)5-6-20-10-19/h6-9,12-13,15,28H,10-11H2,1-5H3,(H,23,24)(H,25,30);1-4,7-9,20,26H,5-6,10-12H2,(H,21,22).
What are the key properties of 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one?
2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one has a molecular weight of 755.93 g/mol, XLogP of 5.01, 7 rotatable bonds, 6 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-(2,7-diazaspiro[3.4]octan-2-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;3-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-6-(1H-pyrazol-4-yl)-1H-pyridin-2-one is sourced from PubChem (CID 157151581), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).